Metformin ER for intermittent claudication

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 24 Nov 2021: Trial registered, NCT05132439
  2. 1 Mar 2022: Trial started, NCT05132439

The trials

NCT05132439: MetfOrmin BenefIts Lower Extremities With Intermittent Claudication

State
Under way
Phase
Phase 3
People
200 planned
Started
1 Mar 2022
Primary completion
28 Feb 2027
Arms
Metformin ER 1000mg
Results
None posted
  1. 24 Nov 2021: Trial registered
  2. 1 Mar 2022: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.